LONDON – Britain says it will become the first country to offer all babies a vaccine for potentially fatal meningitis B after it reached a price deal with GlaxoSmithKline PLC.
Government health advisers recommended use of the Bexsero vaccine last year, and the government has spent months negotiating over the cost.
The drug was owned by Novartis, which recently sold most of its vaccines business to GlaxoSmithKline.
READ MORE: 6 vaccination myths debunked
Health Secretary Jeremy Hunt said Sunday he was “very proud that we will be the first country in the world to have a nationwide Men B vaccination program.”
Babies will receive the vaccine at two months, followed by two further doses.
READ MORE: Why the NHL locker room is the perfect catalyst for a mumps outbreak
Meningitis is a bacterial infection of the lining surrounding the brain and spinal cord that most commonly affects children and teenagers.
- Canadian man dies during Texas Ironman event. His widow wants answers as to why
- Invasive strep: ‘Don’t wait’ to seek care, N.S. woman warns on long road to recovery
- ‘Sciatica was gone’: hospital performs robot-assisted spinal surgery in Canadian first
- ‘Super lice’ are becoming more resistant to chemical shampoos. What to use instead
Comments